Page last updated: 2024-10-17

aminocaproic acid and Blood Diseases

aminocaproic acid has been researched along with Blood Diseases in 4 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research Excerpts

ExcerptRelevanceReference
"To determine the efficacy and safety of antifibrinolytics (lysine analogues) in preventing bleeding in people with haematological disorders."8.93Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. ( Brunskill, SJ; Desborough, M; Doree, C; Estcourt, LJ; Hopewell, S; Murphy, MF; Stanworth, SJ, 2016)
"To determine the efficacy and safety of antifibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders."8.89Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. ( Brunskill, SJ; Doree, C; Estcourt, LJ; Murphy, MF; Stanworth, S; Trivella, M; Wardrop, D, 2013)
"To determine the efficacy and safety of antifibrinolytics (lysine analogues) in preventing bleeding in people with haematological disorders."4.93Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. ( Brunskill, SJ; Desborough, M; Doree, C; Estcourt, LJ; Hopewell, S; Murphy, MF; Stanworth, SJ, 2016)
"To determine the efficacy and safety of antifibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders."4.89Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. ( Brunskill, SJ; Doree, C; Estcourt, LJ; Murphy, MF; Stanworth, S; Trivella, M; Wardrop, D, 2013)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wardrop, D1
Estcourt, LJ2
Brunskill, SJ2
Doree, C2
Trivella, M1
Stanworth, S1
Murphy, MF2
Desborough, M1
Hopewell, S1
Stanworth, SJ1
HASEGAWA, Y1
TSUKADA, R1
SWEENEY, WM1

Reviews

3 reviews available for aminocaproic acid and Blood Diseases

ArticleYear
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    The Cochrane database of systematic reviews, 2013, Jul-29, Issue:7

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Erythrocyte Transfusion; Hematologic Diseases; Hemorrhag

2013
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
    The Cochrane database of systematic reviews, 2016, Mar-15, Volume: 3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Erythrocyte Transfusion; Hematologic Diseases; Hemorrhag

2016
AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.
    The American journal of the medical sciences, 1965, Volume: 249

    Topics: Aminocaproates; Aminocaproic Acid; Blood Coagulation Disorders; Blood Coagulation Tests; Chemical Ph

1965

Other Studies

1 other study available for aminocaproic acid and Blood Diseases

ArticleYear
[RECENT INFORMATION ON THE THERAPY OF BLOOD DISEASES].
    [Chiryo] [Therapy], 1964, Volume: 46

    Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Aminocaproates; Aminocaproic Acid; Anabolic Age

1964